{"id":"https://openalex.org/W1992017000","doi":"https://doi.org/10.1185/03007999009111499","title":"Fluvoxamine and imipramine in the treatment of depressive patients: A double-blind controlled study","display_name":"Fluvoxamine and imipramine in the treatment of depressive patients: A double-blind controlled study","alternate_titles":[],"publication_year":1990,"publication_date":"1990-01-01","ids":{"openalex":"https://openalex.org/W1992017000","doi":"https://doi.org/10.1185/03007999009111499","mag":"1992017000","pmid":"https://pubmed.ncbi.nlm.nih.gov/2125547"},"language":"en","primary_location":{"id":"doi:10.1185/03007999009111499","doi":"https://doi.org/10.1185/03007999009111499","is_oa":false,"landing_page_url":"https://doi.org/10.1185/03007999009111499","pdf_url":null,"source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1992017000"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5062332967","display_name":"Giancarlo Gonella","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Giancarlo Gonella","raw_affiliation_strings":["Neurology Department, S. Francesco Nursing Home, Bergamo, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology Department, S. Francesco Nursing Home, Bergamo, Italy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026267084","display_name":"Gentile Baignoli","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gentile Baignoli","raw_affiliation_strings":["Neurology Department, S. Francesco Nursing Home, Bergamo, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology Department, S. Francesco Nursing Home, Bergamo, Italy","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005363417","display_name":"Ugo Ecari","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ugo Ecari","raw_affiliation_strings":["Mental Health Department, USL RM4, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mental Health Department, USL RM4, Rome, Italy","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.2272,"has_fulltext":false,"cited_by_count":40,"citation_normalized_percentile":{"value":0.91681143,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"12","issue":"3","first_page":"177","last_page":"184"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13118","display_name":"Psychological Treatments and Disorders","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fluvoxamine","display_name":"fluvoxamine","score":1.0},{"id":"https://openalex.org/keywords/imipramine","display_name":"imipramine","score":1.0},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.7429999709129333},{"id":"https://openalex.org/keywords/serotonin-reuptake-inhibitors","display_name":"serotonin reuptake inhibitors","score":0.859000027179718},{"id":"https://openalex.org/keywords/tricyclic-antidepressants","display_name":"tricyclic antidepressants","score":0.972000002861023},{"id":"https://openalex.org/keywords/antidepressant-efficacy","display_name":"antidepressant efficacy","score":0.8799999952316284},{"id":"https://openalex.org/keywords/drug-tolerability","display_name":"drug tolerability","score":0.8429999947547913},{"id":"https://openalex.org/keywords/suicidal-ideation","display_name":"suicidal ideation","score":0.8450000286102295},{"id":"https://openalex.org/keywords/anxiety","display_name":"anxiety","score":0.5479999780654907},{"id":"https://openalex.org/keywords/somatic-symptoms","display_name":"somatic symptoms","score":0.9179999828338623},{"id":"https://openalex.org/keywords/anticholinergic-effects","display_name":"anticholinergic effects","score":0.9350000023841858},{"id":"https://openalex.org/keywords/gastrointestinal-side-effects","display_name":"gastrointestinal adverse effects","score":0.9269999861717224}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8624953627586365},{"id":"https://openalex.org/C2779910183","wikidata":"https://www.wikidata.org/wiki/Q409236","display_name":"Fluvoxamine","level":5,"score":0.8598810434341431},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7995493412017822},{"id":"https://openalex.org/C2776000289","wikidata":"https://www.wikidata.org/wiki/Q5133761","display_name":"Clinical Global Impression","level":4,"score":0.7582337856292725},{"id":"https://openalex.org/C2779145073","wikidata":"https://www.wikidata.org/wiki/Q58396","display_name":"Imipramine","level":3,"score":0.6564111709594727},{"id":"https://openalex.org/C2778689640","wikidata":"https://www.wikidata.org/wiki/Q113259","display_name":"Anticholinergic","level":2,"score":0.6029618978500366},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4740849733352661},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.44548335671424866},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.4222417175769806},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.40079495310783386},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.35865068435668945},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3525227904319763},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.318878173828125},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.23486977815628052},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.22256100177764893},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D003866","descriptor_name":"Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007099","descriptor_name":"Imipramine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007099","descriptor_name":"Imipramine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007099","descriptor_name":"Imipramine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010091","descriptor_name":"Oximes","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010091","descriptor_name":"Oximes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010091","descriptor_name":"Oximes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016666","descriptor_name":"Fluvoxamine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1185/03007999009111499","doi":"https://doi.org/10.1185/03007999009111499","is_oa":false,"landing_page_url":"https://doi.org/10.1185/03007999009111499","pdf_url":null,"source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},{"id":"pmid:2125547","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2125547","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current medical research and opinion","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W173036302","https://openalex.org/W2004899124","https://openalex.org/W2006851386","https://openalex.org/W2010226712","https://openalex.org/W2032884131","https://openalex.org/W2036300683","https://openalex.org/W2043522722","https://openalex.org/W2046777567","https://openalex.org/W2061378977","https://openalex.org/W2065463514","https://openalex.org/W2124755695","https://openalex.org/W2145458328","https://openalex.org/W2292932723","https://openalex.org/W2409187367","https://openalex.org/W2410460503","https://openalex.org/W2412721322","https://openalex.org/W2417628193","https://openalex.org/W2417865122","https://openalex.org/W2433046558","https://openalex.org/W2480534656","https://openalex.org/W2497139934","https://openalex.org/W3090293687","https://openalex.org/W4230097235"],"related_works":["https://openalex.org/W2409187367","https://openalex.org/W2078719282","https://openalex.org/W2417865122","https://openalex.org/W2128772626","https://openalex.org/W2497139934","https://openalex.org/W2046777567","https://openalex.org/W2060435625","https://openalex.org/W2153074711","https://openalex.org/W1996252533"],"abstract_inverted_index":{"A":[0],"double-blind,":[1],"controlled":[2],"study":[3],"was":[4,75,87,134,156,170],"carried":[5],"out":[6],"in":[7,95,160,164,176],"20":[8],"patients":[9],"diagnosed":[10],"as":[11],"suffering":[12],"from":[13],"depressive":[14,161],"disorder":[15],"according":[16],"to":[17,20,41,65,91],"DSM-III":[18],"criteria":[19],"compare":[21],"the":[22,59,81,84,118,124,137,150,153,190,198,202],"effectiveness":[23],"and":[24,63,107,112,128,140,167,180,204],"tolerability":[25],"of":[26,34,50,83,100,115,152,197],"fluvoxamine,":[27],"a":[28,48,70,129,157],"serotonin":[29],"re-uptake":[30],"inhibitor,":[31],"with":[32,201,206],"that":[33,148,168],"imipramine.":[35],"Patients":[36],"were":[37,103,185,193],"allocated":[38],"at":[39,55,77,149],"random":[40],"receive":[42],"one":[43],"or":[44],"other":[45],"drug":[46],"for":[47,58,69,80,122],"period":[49],"4":[51,113],"weeks,":[52],"dosage":[53],"starting":[54],"50":[56],"mg":[57,67,93],"first":[60],"3":[61,72],"days":[62],"increasing":[64],"100":[66],"daily":[68,94],"further":[71],"days.":[73],"Dosage":[74,138],"continued":[76],"this":[78],"level":[79],"remainder":[82],"trial":[85,154],"but":[86,189],"increased,":[88],"if":[89],"necessary,":[90],"150":[92],"two":[96],"divided":[97],"doses.":[98],"Assessments":[99],"symptom":[101],"severity":[102,163],"made":[104],"on":[105],"entry":[106],"response":[108],"after":[109],"1,":[110],"2":[111],"weeks":[114],"treatment":[116],"using":[117,136],"Hamilton":[119],"Rating":[120],"Scale":[121],"Depression,":[123],"Clinical":[125],"Global":[126],"Impression":[127],"Visual":[130],"Analogue":[131],"Scale.":[132,144],"Tolerability":[133],"assessed":[135],"Record":[139],"Treatment":[141],"Emergent":[142],"Symptom":[143],"The":[145],"results":[146],"showed":[147],"end":[151],"there":[155],"significant":[158],"reduction":[159],"symptoms":[162],"both":[165],"groups":[166],"fluvoxamine":[169],"significantly":[171],"more":[172],"effective":[173],"than":[174],"imipramine":[175],"reducing":[177],"suicidal":[178],"ideas":[179],"anxiety/somatic":[181],"symptoms.":[182],"Both":[183],"drugs":[184],"relatively":[186],"well":[187],"tolerated":[188],"side-effect":[191],"profiles":[192],"different,":[194],"being":[195],"mainly":[196],"anticholinergic":[199],"type":[200],"tricyclic":[203],"gastro-intestinal":[205],"fluvoxamine.":[207]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1992017000","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
